Literature DB >> 166911

Serum and tissue proteins in tuberous sclerosis. I. Serum and red-cell polymorphic systems.

A T Rundle, J Atkin, B Sudell.   

Abstract

5 serum protein polymorphic systems (haptoglobin, alkaline phosphatase, group-specific (Gc) proteins, beta2-glycoprotein 1 and leucine aminopeptidase) and 6 red-cell polymorphisms (adenosine deaminase, adenylate kinase, phosphoglucomutase, glutamic-pyruvic transaminase, phosphogluconate dehydrogenase and acid phosphatase) have been investigated in 54 subjects with tuberous sclerosis. The frequencies of all systems were compared with those of a control sample drawn from a similar mentally retarded population and abnormal distributions were detected in the haptoglobin and Gc system. Quantitative estimation of the serum levels of the Gc protein failed to detect any inter-group differences. Data on the deviations from the Hardy-Weinberg equlibrium, Haldane's Log ratio test between groups, and gene frequencies of both test and control groups are given. It is suggested that selection by mortality is the possible causation for the abnormal distribution of the Gc phenotypes, but the haptoglobin phenotype distribution requires further investigation with care being taken in the selection of control subjects.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 166911     DOI: 10.1007/bf00283499

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


  32 in total

1.  Internal manifestations of tuberous sclerosis.

Authors:  W B REED; W R NICKEL; G CAMPION
Journal:  Arch Dermatol       Date:  1963-06

2.  Distribution of the serum group-specific components in Israel.

Authors:  H CLEVE; B RAMOT; A G BEARN
Journal:  Nature       Date:  1962-07-07       Impact factor: 49.962

3.  Congenital neurocutaneous syndromes in childhood.

Authors:  D H CHAO
Journal:  J Pediatr       Date:  1959-10       Impact factor: 4.406

Review 4.  [Serum groups and disease].

Authors:  G G Wendt; J Krüger; I Kindermann
Journal:  Humangenetik       Date:  1968

5.  Serum polymorphisms in Down's syndrome.

Authors:  A T Rundle; J Atkin; B Sudell
Journal:  Humangenetik       Date:  1974

6.  Serum proteins in Down's syndrome.

Authors:  A T Rundle; J Atkin; B Clothier
Journal:  Dev Med Child Neurol       Date:  1973-12       Impact factor: 5.449

7.  Serum alkaline phosphatase isoenzymes in Down's syndrome.

Authors:  A T Rundle; J Atkin
Journal:  Am J Ment Defic       Date:  1971-03

8.  Tuberous sclerosis: a clinical and genetical investigation.

Authors:  J Zaremba
Journal:  J Ment Defic Res       Date:  1968-03

9.  Diagnostic and genetical aspects of tuberous sclerosis.

Authors:  N C Nevin; W G Pearce
Journal:  J Med Genet       Date:  1968-12       Impact factor: 6.318

10.  Clinical and genetic investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis; contribution to elucidation of interrelationship and eugenics of the syndromes.

Authors:  A BORBERG
Journal:  Acta Psychiatr Neurol Scand Suppl       Date:  1951
View more
  2 in total

1.  Molecular analysis of the human vitamin D binding protein (group specific component, Gc) in tuberous sclerosis complex (TSC).

Authors:  J A Rodriguez; R L Evans; S P Daiger; H Northrup
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

2.  Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test.

Authors:  Xingguang Luo; Lingjun Zuo; Henry R Kranzler; Shuang Wang; Raymond F Anton; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2008-09-18       Impact factor: 3.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.